UniSa - IRIS Institutional Research Information System

GIUDICE, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 8.909
NA - Nord America 4.202
EU - Europa 2.536
SA - Sud America 450
AF - Africa 65
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 9
Totale 16.181
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 7.317
US - Stati Uniti d'America 4.147
SG - Singapore 682
IT - Italia 622
DE - Germania 523
RU - Federazione Russa 440
BR - Brasile 395
CN - Cina 378
FI - Finlandia 243
VN - Vietnam 182
ES - Italia 167
IE - Irlanda 124
UA - Ucraina 117
KR - Corea 83
IN - India 73
TR - Turchia 71
GB - Regno Unito 70
AT - Austria 55
SE - Svezia 52
CZ - Repubblica Ceca 39
CA - Canada 29
JP - Giappone 29
NL - Olanda 24
ET - Etiopia 23
BD - Bangladesh 19
AR - Argentina 17
EC - Ecuador 17
ID - Indonesia 16
PL - Polonia 15
MX - Messico 14
ZA - Sudafrica 11
EG - Egitto 10
FR - Francia 10
PK - Pakistan 9
EU - Europa 8
NP - Nepal 7
VE - Venezuela 7
AU - Australia 6
JO - Giordania 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
TH - Thailandia 5
CO - Colombia 4
KE - Kenya 4
MK - Macedonia 4
NZ - Nuova Zelanda 4
PE - Perù 4
PY - Paraguay 4
GR - Grecia 3
HN - Honduras 3
HR - Croazia 3
IQ - Iraq 3
IR - Iran 3
KG - Kirghizistan 3
LT - Lituania 3
LU - Lussemburgo 3
MA - Marocco 3
PT - Portogallo 3
BE - Belgio 2
BJ - Benin 2
CH - Svizzera 2
DZ - Algeria 2
HU - Ungheria 2
JM - Giamaica 2
LC - Santa Lucia 2
LY - Libia 2
MD - Moldavia 2
SA - Arabia Saudita 2
TN - Tunisia 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
CL - Cile 1
CM - Camerun 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GN - Guinea 1
GT - Guatemala 1
IL - Israele 1
IS - Islanda 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
PH - Filippine 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TJ - Tagikistan 1
UY - Uruguay 1
Totale 16.180
Salva come PNG Salva come JPEG
Città #
Hong Kong 7.306
Dallas 578
Ann Arbor 465
Chandler 453
Munich 390
Woodbridge 326
Princeton 305
Ashburn 303
Singapore 268
Wilmington 188
Houston 157
Valencia 156
Jacksonville 148
Helsinki 144
Naples 124
Dong Ket 112
Dublin 108
Moscow 89
Beijing 80
Nuremberg 66
Salerno 63
Los Angeles 59
Andover 57
Izmir 57
Boardman 43
Rome 42
Turku 42
São Paulo 37
Brno 36
Redwood City 35
Nanjing 34
Washington 33
Ho Chi Minh City 31
Fisciano 24
New York 24
Santa Clara 24
Addis Ababa 23
Pellezzano 23
Pune 23
Brooklyn 22
Milan 22
Vienna 22
Rio de Janeiro 20
Düsseldorf 18
Fairfield 18
Changsha 17
Jyväskylä 17
The Dalles 17
Columbus 16
Seattle 16
Stockholm 15
Tokyo 15
Amsterdam 14
Council Bluffs 14
Norwalk 14
Seoul 14
Hanoi 13
Manchester 13
Lappeenranta 12
Nanchang 12
Warsaw 12
Belo Horizonte 11
Boston 11
Chennai 11
Guangzhou 11
London 11
Tianjin 11
West Jordan 11
Quito 10
Brasília 9
Curitiba 9
San Francisco 9
Toronto 9
Cambridge 8
Cava de' Tirreni 8
Domicella 8
Montreal 8
Phoenix 8
Shenyang 8
Buffalo 7
Caserta 7
Catania 7
Charlotte 7
Kathmandu 7
Richmond 7
Shanghai 7
Amman 6
Atlanta 6
Chicago 6
Dearborn 6
Dhaka 6
Jakarta 6
Mumbai 6
Pisa 6
Porto Alegre 6
San Prisco 6
Blumenau 5
Campinas 5
Casoria 5
Cava De' Tirreni 5
Totale 13.129
Salva come PNG Salva come JPEG
Nome #
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study 863
Mucosal-Associated Invariant T Cells in T-Cell Non-Hodgkin Lymphomas: A Case Series 681
Low-Density Granulocytes Are Decreased in Acute Myeloid Leukemia and in Myelodysplastic Syndromes with Negative Prognostic Factors 614
Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia 448
Aplastic anemia: Pathophysiology 440
DECREASED LOW-DENSITY GRANULOCYTES AS POSSIBLE DIAGNOSTIC MARKERS OF MYELODYSPLASTIC SYNDROMES WITH EXCESS OF BLASTS 438
Suitability of Different Cytological Preparations for Molecular Analysis of Advanced Non-Small Cell Lung Cancers 433
Hodgkin Lymphoma and Hairy Cell Leukemia Arising from Chronic Lymphocytic Leukemia: Case Reports and Literature Review 382
Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma 325
Chondrogenic Commitment of human Bone Marrow Mesenchymal Stem Cells in a perfused, hTGF-β1-releasing PLGA microcarrier seeded, collagen hydrogel 319
Immature forms of low density granulocytes are increased in acute myeloid leukemia and myelodysplastic syndromes 303
WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes 285
Cell-free regenerative medicine: identifying the best source of mesenchymal stem cells for skin therapy in Systemic Sclerosis 284
A Rare Immune-Related Mesenteric and retroperitoneal serositis in a Multi-Refractory Hodgkin Lymphoma Patient Successfully Treated with Chylolymphostatic Surgery 278
Involvement of soluble forms of receptor of the urokinase-type plasminogen activator (UPAR) in hematopoietic stem cell homing 263
All Roads Lead to Interferon-γ: From Known to Untraveled Pathways in Acquired Aplastic Anemia 260
High-Risk Genetic Multiple Myeloma: From Molecular Classification to Innovative Treatment with Monoclonal Antibodies and T-Cell Redirecting Therapies 251
Effects of selected preanalytical variables on Dried Blood Spot (DBS) and Volumetric Adsorptive Microsampling (VAMS) based bioanalytical methods for the determination of four β-lactam antibiotics 205
Clinical efficacy of azacytidine and venetoclax and prognostic impact of Tim-3 and galectin-9 in acute myeloid leukemia and high-risk myelodysplastic syndromes: A single-center real-life experience 193
Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma 188
Contribution of peripheral blood mononuclear cells isolated by advanced filtration system to myogenesis of human bone marrow mesenchymal stem cells co-cultured with myoblasts 187
Aptamer-based proteomics of serum and plasma in acquired aplastic anemia 186
Gender Differences in the Impact of COVID-19 Pandemic on Mental Health of Italian Academic Workers 184
Eltrombopag Improves Hematopoiesis in Patients with Low to Intermediate-2 Risk Myelodysplastic Syndrome (MDS). 168
Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab-based regimens 157
Autologous And Allogeneic Stem Cell Transplantation Is Associated With Long-Lasting Endocrine Disorders 152
Accelerated and persistent bone loss after autologous and allogeneic stem cell transplantation 144
Bone marrow mesenchymal stem cells as a possible ruxolitinib reservoir in the bone marrow niche 141
Lenalidomide-Mediated NK Cells Expansion In Elderly Multiple Myeloma Patients 140
High incidence of cytomegalovirus reactivation in patients with lymphoma treated with bendamustine 140
The Role of B Regulatory Cells in the Immunological Escape of Tumor Cells in Hodgkin Lymphoma 133
3D Biomimetic Scaffold for Growth Factor Controlled Delivery: An in-vitro study of Tenogenic events on Wharton’s Jelly Mesenchymal stem cells 130
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation increases the number of circulating natural killer cells 129
Anaplastic CD30+ alk- (micro) lymphoma arising out of mediastinal Plasma Cell Castleman’s disease in immunocompetent patient treated by rituximab- dexametasone and continuous lenalidomide 127
Prolonged low-dose lenalidomide treatment increases the number of circulating natural killer cells in multiple mieloma patients 124
67 KDA laminin receptor (67LR) in normal and neoplastic hematopoietic cells: is its targeting a feasible approach? 124
Circulating T Regulatory Cells Are Persistently Reduced in Non-Severe Acquired Aplastic Anemia 121
Prolonged azacitidine treatment in the management of elderly patients with high risk myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia not eligible for standard intensive therapy 121
Prophylactic therapy with oral low-dose valgancyclovir in cytomegalovirus-positive allogeneic stem cell transplant recipients 120
3D in-vitro cultures of human bone marrow and Wharton’s jelly derived mesenchymal stromal cells show high chondrogenic potential 118
Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia. 109
Induction therapy with continuous alternate-day low dose lenalidomide combined with low-dose prednisone in octogenarian Multiple Myeloma patients 108
Sirt-1 as a novel therapeutic target for improving nitric oxide release in heterozygous and homozygous patients for mthfr mutations 107
Cytomegalovirus reactivation prophylaxis with low dose valgancyclovir after hematopoietic stem cell transplantation 105
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation 104
Urokinase type plasminogen activator receptor (UPAR) as a new therapeutic target in cancer. 104
Daily low-dose valgancyclovir is safe and effective CMV-reactivation prophylaxis in HLA-identical sibling hematopoietic stem cell transplantation. Bone Marrow Transplantation 103
Electrophysiological Studies in Combination With Interim-Positron Emission Tomography Scan for Prevention of Severe Brentuximab-Vedotin-Induced Neurotoxicity 101
In vitro apoptotic effects of farnesyltransferase blockade in acute myeloid leukemia cells. 99
Flow Cytometric Detection Of B-cell Membrane Markers CD5, CD11c, CD20, CD38 And CD49d May Predict Outcome In Chronic Lymphocytic Leukemia And Non-Hodgkin Lymphoma 98
Role of Laparoscopic Splenectomy in Elderly Immune Thrombocytopenia. 95
Endocrine disorders after autologous and allogeneic stem cell transplantation 94
Reproductive issues in patients undergoing Hematopoietic Stem Cell Transplantation: an update 91
Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. 89
Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment. 88
Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases 88
A simple flow cytometric score based on CD49d and homing marker expression in chronic lymphocytic leukemia (CLL). 88
Pre- and Post-COVID-19 Antibiotic Consumption and Stewardship Program in a Southern Italian Hospital 87
Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens 82
Therapeutic drug monitoring might identify poor responders to ruxolitinib treatment in myeloproliferative neoplasms 81
Combined liposomal amphotericin b and surgery as successful management for pulmunary mucormycosis in a patient with acute myeloid leukemia 80
Stem Cells from Healthy and Tendinopathic Human Tendons: Morphology, Collagen and Cytokines Expression and Their Response to T3 Thyroid Hormone 80
Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic hematopoietic stem cell transplantation 79
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency 77
Safety of Adjuvanted Recombinant Herpes Zoster Virus Vaccination in Fragile Populations: An Observational Real-Life Study 77
Bone Marrow Failure Syndromes, Overlapping Diseases with a Common Cytokine Signature 74
Stem cell and macrophage roles in skeletal muscle regenerative medicine 72
BONE MARROW MESENCHYMAL STEM CELLS AS FACILITATOR OF RUXOLITINIB-MEDIATED INHIBITION OF JAK2 MUTADED CELLS 72
Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic haematopoietic stem cell transplantation. 71
Advanced biopolymer filtration system for Peripheral Blood Mononuclear Cells collection: a study on filter composition and in vitro filtrate composition 68
Peripheral blood mononuclear cells contribute to myogenesis in a 3D bioengineered system of bone marrow mesenchymal stem cells and myoblasts 67
Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation 64
How to Improve the Definition of Chronic Lymphocytic Leukemia Outcome Using a Simple Flow Cytometric Score Based on CD49d and Homing Marker Expression 64
Daily low-dose valgancyclovir is safe and effective CMV-reactivation prophylaxis in HLA-identical sibling hematopoietic stem cell transplantation 63
Identification of uPAR Variants Acting as ceRNAs in Leukaemia Cells 63
Real-world experience with the Sydney System on 1458 cases of lymph node fine needle aspiration cytology 62
Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma 62
Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters 61
Successful management of pulmonary mucormycosis with liposomal amphotericin B and surgery treatment: a case report 60
A case series of blastic plasmacytoid dendritic cell neoplasia 60
Can we turn off the “Covid-biting-tail” inflammation? 60
Myogenic commitment of human stem cells by myoblasts Co-culture: a static vs. a dynamic approach 60
OPSI threat in hematological patients 59
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 58
A Frail Hairy Cell Leukemia Patient Successfully Treated with Pegylated Interferon-α-2A 55
Prophylactic letermovir decreases cytomegalovirus reactivation after stem cell transplantation: a single-center real-world evidence study 55
BRAF V600E mutation associated with papillary high-grade serous ovarian cystadenocarcinoma in a 22q11.2DS patient 53
Fluorescent Cell Barcoding for Immunophenotyping 49
Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson's Disease 47
Pharmacovigilance of Selective Serotonin Reuptake Inhibitors and Gender Differences in Stroke Incidence 47
Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies 46
c-Kit M541L variant is related to ineffective hemopoiesis predisposing to clonal evolution in 3D in vitro biomimetic co-culture model of bone marrow niche 46
Sicurezza del vaccino ricombinante anti-herpes Zoster virus in popolazioni fragili: uno studio osservzionale 46
Reduced Proliferative Potential with Conserved Stem/Stromal Phenotype of Human Umbilical Cord Mesenchymal Stem Cells in Placental Syndromes: A Prospective Cohort Study 45
Sex-tailored pharmacology and COVID-19: next steps towards appropriateness and health equity 45
Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience 44
Implementation of International Prognostic Index with flow cytometry immunophenotyping for better risk stratification of chronic lymphocytic leukemia 44
Biomimetic proteolipid vesicles for reverting GPI deficiency in paroxysmal nocturnal hemoglobinuria 44
Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome 44
Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B 43
Totale 14.586
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.948
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.948
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021450 0 0 0 2 103 28 42 11 29 39 58 138
2021/2022569 14 2 14 43 16 15 4 17 72 46 75 251
2022/20231.182 94 108 85 129 111 209 54 122 155 4 58 53
2023/2024921 77 90 73 59 71 162 71 71 17 40 53 137
2024/20252.716 76 36 42 84 173 277 662 249 447 122 253 295
2025/20268.966 1.420 3.933 3.465 148 0 0 0 0 0 0 0 0
Totale 16.467